22nd Century Group Announces 1-for-20 Reverse Stock Split and Corrects Inducement Warrant Terms
Summary
22nd Century Group announced a 1-for-20 reverse stock split to meet NASDAQ listing requirements and amended a prior filing to correct the exercise price of inducement warrants to $3.57, while also raising $462,800 in net cash and redeeming $2.01 million in preferred stock.
Key Events
-
1-for-20 Reverse Stock Split Announced
The company will effect a 1-for-20 reverse stock split, effective June 12, 2026, to regain compliance with NASDAQ Capital Market listing standards. This will reduce outstanding shares from approximately 10.3 million to 516,328.
-
Inducement Warrant Exercise Price Corrected
An amendment corrects the exercise price of newly issued Inducement Warrants from $0.4626 to $3.57. This significantly improves the terms for the company, as future exercises will bring in more capital at a higher price.
-
Warrant Inducement Offering Completed
The company received approximately $462,800 in gross cash proceeds from the exercise of existing warrants. Additionally, $2,010,000 of Series B Preferred Stock was redeemed using proceeds from the warrant exercises.
-
Significant Potential Dilution from New Warrants
In connection with the inducement, the company will issue new warrants to purchase up to 5,345,591 shares of common stock, representing substantial potential dilution if fully exercised.
Analysis
This filing announces a critical 1-for-20 reverse stock split, effective June 12, 2026, primarily to regain compliance with NASDAQ listing standards. This is a significant event for a company already facing 'going concern' doubts and trading near its 52-week low. Concurrently, an amendment corrects the exercise price of newly issued inducement warrants from $0.4626 to $3.57. While the company received $462,800 in net cash proceeds and redeemed $2.01 million in Series B Preferred Stock through a warrant inducement offering, the issuance of over 5.3 million new warrants at the corrected higher exercise price still represents substantial potential dilution. The reverse split, coupled with ongoing dilutive financing, underscores the company's precarious financial position.
At the time of this filing, XXII was trading at $0.43 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $2.3M. The 52-week trading range was $0.45 to $257.03. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.